News
Persica Pharmaceuticals Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel, non-opioid intradiscal injection for the treatment of chronic Low Back Pain The PP353 ...
Persica Pharmaceuticals. Peter Hamlyn, Founder and Director of Persica Pharmaceuticals will be presenting at the British Association of Spine Surgeons. London, UK, 24 March 2022 – Persica ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback